The more the stakeholders in the clinical research enterprise can foster the “we’re all in this together” attitude, the more wins we will all chalk up as we map the way to modern trials.
It is now more important than ever to understand the intricacies of the clinical and regulatory pathways for life-saving phage therapies.
Decentralized, adaptive, and complex innovative trial designs require biometrics teams to push the boundaries of data analysis.
Once you’ve secured a sponsored clinical trial site, how can you make sure that the study runs smoothly and you are capturing all the revenue that your site is due?
"We need to embrace the challenges that creating truly diverse, patient-focused clinical trials brings," says a drug development expert with more than 40 years of insight on the matter.